Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-011394
Filing Date
2024-02-05
Accepted
2024-02-05 18:07:48
Documents
1
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7333
  Complete submission text file 0000950170-24-011394.txt   8858
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET NEW YORK NY 10016
Business Address
Neumann Mark (Reporting) CIK: 0001756211 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36274 | Film No.: 24597242